Pharmaceutical

STAT+: Complications spiked 25% in hospitals bought by ...

Adverse events at hospitals like falls and infections spiked 25% after private e...

Opinion: Does food as medicine help patients with diabe...

Does food as medicine help patients with diabetes? Here’s what a new clinical tr...

STAT+: With Biden finalizing an Apple Watch ban, Apple ...

President Biden finalized an import ban of latest Apple Watches after the ITC de...

STAT+: Bristol Myers will pay $4.1 billion for cancer s...

Bristol Myers Squibb will pay $4.1 billion for RayzeBio, buying into the fast-gr...

STAT+: New weight loss drugs have proven their effectiv...

A team of researchers will soon launch a study driven by a pressing question in ...

STAT+: 3 CRISPR advances to watch in 2024

Approval of the first CRISPR-based medicine paves the way for in vivo therapies,...

STAT+: 3 medtech trends to watch in 2024

STAT looks at the forces that shaped the medical devices industry last year, and...

AZD-9550 by AstraZeneca for Metabolic Dysfunction-Assoc...

AZD-9550 is under clinical development by AstraZeneca and currently in Phase I f...

GS-4528 by Gilead Sciences for Metastatic Renal Cell Ca...

GS-4528 is under clinical development by Gilead Sciences and currently in Phase ...

ADRX-0706 by Adcentrx Therapeutics for Head And Neck Sq...

ADRX-0706 is under clinical development by Adcentrx Therapeutics and currently i...

BGB-30813 by BeiGene for Head And Neck Squamous Cell Ca...

BGB-30813 is under clinical development by BeiGene and currently in Phase I for ...

NT-175 by Neogene Therapeutics for Head And Neck Squamo...

NT-175 is under clinical development by Neogene Therapeutics and currently in Ph...

ORB-011 by Orionis Biosciences for Head And Neck Squamo...

ORB-011 is under clinical development by Orionis Biosciences and currently in Ph...

ODM-212 by Orion for Solid Tumor: Likelihood of Approval

ODM-212 is under clinical development by Orion and currently in Phase I for Soli...

KB-707 by Krystal Biotech for Solid Tumor: Likelihood o...

KB-707 is under clinical development by Krystal Biotech and currently in Phase I...

RO-7566802 by Genentech USA for Solid Tumor: Likelihood...

RO-7566802 is under clinical development by Genentech USA and currently in Phase...